Evidence map›Paper›PMID 31662305›Full record

Trial reportDiabetes care2020

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function.

Erik J M van Bommel, Danique Ruiter, Marcel H A Muskiet, Michaël J B van Baar, Mark H H Kramer, Max Nieuwdorp, Jaap A Joles, Petter Bjornstad, Daniël H van Raalte

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Diabetes care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Redox regulation in diabetic kidney disease.American journal of physiology. Renal physiology · 2023
    Review
  9. Review
  10. Neutralizing MIP3The Journal of pharmacology and experimental therapeutics · 2023
    Article
  11. Article
  12. Article
  13. Observational
  14. Mechanisms of Cardiorenal Protection of Glucagon-Like Peptide-1 Receptor Agonists.Advances in chronic kidney disease · 2021 · on this map
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Erik J M van BommelDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, the Netherlands e.vanbommel@amsterdamumc.nl.ORCID 0000-0002-5583-7348
Danique RuiterDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, the Netherlands.
Marcel H A MuskietDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, the Netherlands.
Michaël J B van BaarDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, the Netherlands.ORCID 0000-0003-1516-2929
Mark H H KramerDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, the Netherlands.
Max NieuwdorpDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, the Netherlands.ORCID 0000-0002-1926-7659
Jaap A JolesDepartment of Nephrology and Hypertension, University Medical Center, Utrecht, the Netherlands.
Petter BjornstadDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.ORCID 0000-0002-5160-2947
Daniël H van RaalteDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, the Netherlands.
Amsterdam University Medical Centers · NLUniversity Medical Center Utrecht · NLUniversity of Colorado Denver · US

Funding

Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes StudyK23DK116720 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BJORNSTAD, PETTER · 2018 to 2022
$963k
NIDDK NIH HHS K23 DK116720
6 · The paper itself

Abstract

objectiveImpaired insulin sensitivity is associated with hyperfiltration (i.e., elevated glomerular filtration rate [GFR]) in adolescents with type 2 diabetes (T2D) and adults with prediabetes. Yet, these relationships are based on studies that relied on estimated GFR (eGFR), estimates of insulin sensitivity, or both. We aimed to verify the relationship between insulin sensitivity and renal hemodynamic function by gold standard methods in adults with T2D. RESEARCH DESIGN AND

methodsInsulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp (M value) (glucose infusion rate in mg/kg

resultsWe tested 44 adults with T2D, of whom 77% were male, with mean ± SD age 63 ± 7 years, BMI 31.2 ± 4.0 kg/m

conclusionsFor the first time, we demonstrate that impaired insulin sensitivity is associated with intrarenal hemodynamic dysfunction by gold standard techniques in adults with T2D treated with metformin monotherapy.

Indexed as

HemodynamicsAdultAgedBenzhydryl CompoundsCross-Sectional StudiesCytoprotectionDiabetes Mellitus, Type 2FemaleGlomerular Filtration RateGlucose Clamp TechniqueGlucosidesHumansInsulin ResistanceKidneyMaleMetforminBenzhydryl CompoundsdapagliflozinGlucosidesMetformin

Identifiers

PMID31662305
PMCPMC7118247
OpenAlexW2982628440

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.